Susan Berlam, RPh, MS Pfizer, Inc.

Susan received her B.S. in Pharmacy from the University of Rhode Island and M.S. in Regulatory Affairs from Temple University. Susan is a registered pharmacist in Rhode Island.

Susan joined Pfizer Central Research in Pharmaceutical R&D in 1984 where she was spent 6 years developing formulations for sterile injectables, topicals, ophthalmics and oral solutions and suspensions. She then moved on to manage the clinical Liquid Dosage Manufacturing facility for ten years. In 2000, Susan joined a consulting firm, Drumbeat Dimensions as Vice President of Validation. Upon returning to Pfizer R&D 2 years later, Susan joined Quality Assurance where she led several QA teams in drug substance and drug product release and late stage co-development. She later took on a leadership role in Global Regulatory CMC where she has worked since 2006. Here she directs a team of scientists responsible for developing and overseeing global regulatory strategies and CMC submissions across the lifecycle of the product, beginning with the First in Human study and through to commercialization and loss of exclusivity. She has been a key contributor to a numerous marketing applications and hundreds of investigational applications.